TARO PHAR.INDS. IS 0,0001
TARO PHAR.INDS. IS 0,0001/ IL0010827181 /
TAL
|
27.05.2024 08:08:08
|
Diff.
-0,2000
|
Volumen |
Geld07:31:26 |
Brief07:31:26 |
Marktkapitalisierung |
Dividendenr. |
KGV |
|
39,2000EUR
|
-0,51%
|
0
Umsatz: 0.0000 |
39,0000Geld Vol: 200 |
39,4000Brief Vol: 200 |
1,47 Mrd.EUR |
- |
- |
Unternehmensportrait
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products.
Vorstand & Aufsichtsrat
| Vorstandsvorsitzender |
| Uday Baldota |
| Vorstand |
| William J. Coote, Vikash Agarwal, Avi Avramoff, Victoria Chester, Anthony Dolan, Moshe Gavrilov, Nivaran Kapur, David Kinzelberg, Karen Lowney, Barb Pimentel, Hagai Reingold, Michele Visosky, Erik Zwicker |
| Aufsichtsrat |
| Dilip Shanghvi, Abhay Gandhi, Uday Baldota, Linda Benshoshan, James Kedrowski, Dr. Robert Stein, Sudhir Valia |
Unternehmensinformationen
| Name: |
Taro Pharmaceutical Industrie |
| Adresse: |
14 Hakitor Street, Haifa Bay,Haifa 2624761 |
| Telefon: |
+972 4 847 5700 |
| Fax: |
- |
| E-Mail: |
-
|
| Internet: |
https://www.taro.com/ |
| Industrie: |
Gesundheitswesen |
| Sektor: |
Pharmazeutische Industrie |
| Sub-Sektor: |
Pharmazeutische Industrie |
| Ende des Finanzjahres: |
30.03 |
| Streubesitz: |
- |
| IPO Datum: |
01.01.1961 |
Hauptaktionäre
| Sun |
|
78,50% |
| Sonstige |
|
21,50% |
